Mitochondrial Dysfunction in Lung Pathogenesis

Annual Review of Physiology

Volumn 79, Issue , 2017, Pages 495-515

  Piantadosi, Claude A ^a   Suliman, Hagir B ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammasome; Mitochondrial biogenesis; Mitophagy; Oxidants; Reactive oxygen species; Respiration

Indexed keywords

INFLAMMASOME;

ACUTE LUNG INJURY; APOPTOSIS; CHRONIC INFLAMMATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG TARGETING; HUMAN; IMMUNE RESPONSE; INFLAMMATION OF THE LUNGS, BRONCHI AND PLEURA; INTRACELLULAR SIGNALING; LUNG; LUNG CANCER; LUNG CARCINOGENESIS; LUNG DISEASE; LUNG FIBROSIS; MITOCHONDRION; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; ANIMAL; INFLAMMATION; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; INFLAMMATION; LUNG; LUNG DISEASES; MITOCHONDRIA; SIGNAL TRANSDUCTION;

EID: 85013040966     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-022516-034322     Document Type: Review

References (148)

1. ShadelGS, HorvathTL. 2015. MitochondrialROSsignaling in organismal homeostasis. Cell 163(3):560-69
2. Piantadosi CA, Suliman HB. 2012. Transcriptional control of mitochondrial biogenesis and its interface with inflammatory processes. Biochim. Biophys. Acta 1820(4):532-41
3. Vartak R, Porras CA, Bai Y. 2013. Respiratory supercomplexes: structure, function and assembly. Protein Cell 4(8):582-90
4. Ikeda K, Shiba S, Horie-Inoue K, Shimokata K, Inoue S. 2013. A stabilizing factor for mitochondrial respiratory supercomplex assembly regulates energy metabolism in muscle. Nat. Commun. 4:2147
5. Gail DB, Lenfant CJ. 1983. Cells of the lung: biology and clinical implications. Am. Rev. Respir. Dis. 127(3):366-87
6. Fisher AB, Steinberg H, Bassett D. 1974. Energy utilization by the lung. Am. J. Med. 57(3):437-46
7. Williamson JR, Corkey BE. 1979. Assay of citric acid cycle intermediates and related compounds-update with tissue metabolite levels and intracellular distribution. Methods Enzymol. 55:200-22
8. Mustafa MG, Cross CE. 1974. Effects of short-term ozone exposure on lung mitochondrial oxidative and energy metabolism. Arch. Biochem. Biophys. 162(2):585-94
9. Hüttemann M, Lee I, Gao X, Pecina P, Pecinova A, et al. 2012. Cytochrome c oxidase subunit 4 isoform 2-knockout mice show reduced enzyme activity, airway hyporeactivity, and lung pathology. FASEB J. 26(9):3916-30
10. CarrawayMS, Suliman HB, KlimentC,Welty-WolfKE, Oury TD, PiantadosiCA. 2008. Mitochondrial biogenesis in the pulmonary vasculature during inhalational lung injury and fibrosis. Antioxid. Redox Signal. 10(2):269-75
11. Zou C, Synan MJ, Li J, Xiong S, Manni ML, et al. 2016. LPS impairs oxygen utilization in epithelia by triggering degradation of the mitochondrial enzyme Alcat1. J. Cell Sci. 129(1):51-64
12. Massaro GD, Gail DB, Massaro D. 1975. Lung oxygen consumption and mitochondria of alveolar epithelial and endothelial cells. J. Appl. Physiol. 38(4):588-92
13. Barkauskas CE, Cronce MJ, Rackley CR, Bowie EJ, Keene DR, et al. 2013. Type 2 alveolar cells are stem cells in adult lung. J. Clin. Investig. 123(7):3025-36
14. MoriguchiK,Higashi N, Kitagawa S,TakaseK,OhyaN, et al. 1984. Differentiation of human pulmonary alveolar epithelial cells revealed by peroxisome changes in pulmonary proteinosis. Exp. Mol. Pathol. 40(2):262-70
15. Hirai K, Ogawa K. 1986. Cytochemical quantitation of cytochrome oxidase activity in rat pulmonary alveolar epithelial cells and possible defect in type I cells. J. Electron. Microsc. 35(1):19-28
16. Schumacker PT, Gillespie MN, Nakahira K, Choi AM, Crouser ED, et al. 2014. Mitochondria in lung biology and pathology: more than just a powerhouse. Am. J. Physiol. Lung. CellMol. Physiol. 306(11):L962-74
17. Nunnari J, Suomalainen A. 2012. Mitochondria: in sickness and in health. Cell 148(6):1145-59
18. ChaMY, Kim DK,Mook-Jung I. 2015. The role ofmitochondrialDNAmutation on neurodegenerative diseases. Exp. Mol. Med. 47:e150
19. Liu TF, Vachharajani V, Millet P, Bharadwaj MS, Molina AJ, McCall CE. 2015. Sequential actions of SIRT1-RELB-SIRT3 coordinate nuclear-mitochondrial communication during immunometabolic adaptation to acute inflammation and sepsis. J. Biol. Chem. 290(1):396-408
20. Zhou R, Yazdi AS, Menu P, Tschopp J. 2011. A role for mitochondria in NLRP3 inflammasome activation. Nature 469:221-25
21. Gu X, Wu G, Yao Y, Zeng J, Shi D, et al. 2015. Intratracheal administration of mitochondrial DNA directly provokes lung inflammation through the TLR9-p38 MAPK pathway. Free Radic. Biol. Med. 83:149-58
22. Block K, Gorin Y, Abboud HE. 2009. Subcellular localization ofNox4 and regulation in diabetes. PNAS 106(34):14385-90
23. Ago T, Kuroda J, Pain J, Fu C, Li H, Sadoshima J. 2010. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ. Res. 106(7):1253-64
24. Dranka BP, Hill BG, Darley-Usmar VM. 2010. Mitochondrial reserve capacity in endothelial cells: the impact of nitric oxide and reactive oxygen species. Free Radic. Biol. Med. 48(7):905-14
25. Chandel NS. 2014. Mitochondria as signaling organelles. BMC Biol. 12:34
26. Rizzuto R, De Stefani D, Raffaello A, Mammucari C. 2012. Mitochondria as sensors and regulators of calcium signalling. Nat. Rev. Mol. Cell Biol. 13(9):566-78
27. Szabadkai G, Simoni AM, Bianchi K, De Stefani D, Leo S, et al. 2006. Mitochondrial dynamics and Ca2+ signaling. Biochim. Biophys. Acta 1763(5-6):442-49
28. Dromparis P, Michelakis ED. 2013. Mitochondria in vascular health and disease. Annu. Rev. Physiol. 75:95-126
29. Kleine T, Leister D. 2016. Retrograde signaling: organelles go networking. Biochim. Biophys. Acta 1857:1313-25
30. Sena LA, Chandel NS. 2012. Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 48(2):158-67
31. Metallo CM, VanderHeidenMG. 2010. Metabolism strikes back:metabolic flux regulates cell signaling. Genes Dev. 24(24):2717-22
32. KaelinWGJr., McKnight SL. 2013. Influence of metabolism on epigenetics and disease. Cell 153(1):56-69
33. Pearce EL, Poffenberger MC, Chang CH, Jones RG. 2013. Fueling immunity: insights into metabolism and lymphocyte function. Science 342:1242454
34. Gazdhar A, Lebrecht D, Roth M, Tamm M, Venhoff N, et al. 2014. Time-dependent and somatically acquired mitochondrial DNA mutagenesis and respiratory chain dysfunction in a scleroderma model of lung fibrosis. Sci. Rep. 4:5336
35. Green DR, Llambi F. 2015. Cell death signaling. Cold Spring Harb. Perspect. Biol. 7(12):a006080
36. Santos JH,HunakovaL,ChenY,Bortner C, Van Houten B. 2003. Cell sorting experiments link persistent mitochondrial DNA damage with loss of mitochondrial membrane potential and apoptotic cell death. J. Biol. Chem. 278(3):1728-34
37. BuenoM, Lai YC, Romero Y, Brands J, Croix CM, et al. 2015. PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis. J. Clin. Investig. 125(2):521-38
38. Buder-Hoffmann SA, Shukla A, Barrett TF, MacPherson MB, Lounsbury KM, Mossman BT. 2009. A protein kinaseC-dependent protein kinaseDpathwaymodulates ERK1/2 and JNK1/2 phosphorylation and Bim-associated apoptosis by asbestos. Am. J. Pathol. 174(2):449-59
39. Lounsbury KM, Stern M, Taatjes D, Jaken S, Mossman BT. 2002. Increased localization and substrate activation of protein kinase C in lung epithelial cells following exposure to asbestos. Am. J. Pathol. 160(6):1991-2000
40. Jornayvaz FR, Shulman GI. 2010. Regulation of mitochondrial biogenesis. Essays Biochem. 47:69-84
41. Athale J, Ulrich A, MacGarvey NC, Bartz RR, Welty-Wolf KE, et al. 2012. Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice. Free Radic. Biol. Med. 53(8):1584-94
42. Scarpulla RC. 2008. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 88(2):611-38
43. Suliman HB, Carraway MS, Tatro LG, Piantadosi CA. 2007. A new activating role for CO in cardiac mitochondrial biogenesis. J. Cell Sci. 120(Pt. 2):299-308
44. Terman A, Kurz T, Navratil M, Arriaga EA, Brunk UT. 2010. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid. Redox Signal. 12(4):503-35
45. Haynes CM, Ron D. 2010. The mitochondrial UPR-protecting organelle protein homeostasis. J. Cell Sci. 123(Pt. 22):3849-55
46. Lee J, Giordano S, Zhang J. 2012. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J. 441(2):523-40
47. Novak I, Kirkin V,McEwan DG, Zhang J,Wild P, et al. 2010. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep. 11(1):45-51
48. Liu L, Feng D, Chen G, Chen M, Zheng Q, et al. 2012. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat. Cell Biol. 14(2):177-85
49. Ding WX,NiHM, Li M, Liao Y, Chen X, et al. 2010. Nix is critical to two distinct phases ofmitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. J. Biol. Chem. 285(36):27879-90
50. Chan NC, Salazar AM, Pham AH, Sweredoski MJ, Kolawa NJ, et al. 2011. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum. Mol. Genet. 20(9):1726-37
51. Yoshii SR, Kishi C, Ishihara N, Mizushima N. 2011. Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J. Biol. Chem. 286(22):19630-40
52. Geisler S, Holmström KM, Skujat D, Fiesel FC, Rothfuss OC, et al. 2010. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 12(2):119-31
53. Narendra D, Tanaka A, Suen DF,YouleRJ. 2008. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183(5):795-803
54. Mao K, Wang K, Liu X, Klionsky DJ. 2013. The scaffold protein Atg11 recruits fission machinery to drive selective mitochondria degradation by autophagy. Dev. Cell 26(1):9-18
55. Twig G, Hyde B, Shirihai OS. 2008. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim. Biophys. Acta 1777(9):1092-97
56. Egan D, Kim J, Shaw RJ, Guan KL. 2011. The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR. Autophagy 7(6):643-44
57. Suliman HB, Carraway MS, Piantadosi CA. 2003. Postlipopolysaccharide oxidative damage of mitochondrial DNA. Am. J. Respir. Crit. Care Med. 167(4):570-79
58. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, et al. 2010. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464:104-7
59. Sun S, Sursal T, Adibnia Y, Zhao C, Zheng Y, et al. 2013. Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways. PLOS ONE 8(3):e59989
60. Medzhitov R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449:819-26
61. West AP,Brodsky IE, RahnerC,Woo DK,Erdjument-Bromage H, et al. 2011.TLRsignalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 472(7344):476-80
62. Collins LV, Hajizadeh S, Holme E, Jonsson IM, Tarkowski A. 2004. Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J. Leukoc. Biol. 75(6):995-1000
63. Hou Q, Jin J, Zhou H, Novgorodov SA, Bielawska A, et al. 2011. Mitochondrially targeted ceramides preferentially promote autophagy, retard cell growth, and induce apoptosis. J. Lipid Res. 52(2):278-88
64. Zhao Y, SunX,Nie X, SunL,TangTS, et al. 2012.COX5Bregulates MAVS-mediated antiviral signaling through interaction with ATG5 and repressing ROS production. PLOS Pathog. 8(12):e1003086
65. Subramanian N, Natarajan K, Clatworthy MR, Wang Z, Germain RN. 2013. The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation. Cell 153(2):348-61
66. Chang CH, Curtis JD, Maggi LB Jr., Faubert B, Villarino AV, et al. 2013. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153(6):1239-51
67. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, et al. 2011. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12(3):222-30
68. Suliman HB, Piantadosi CA. 2014. Mitochondrial biogenesis: regulation by endogenous gases during inflammation and organ stress. Curr. Pharm. Des. 20(35):5653-62
69. Chang AL, Ulrich A, Suliman HB, Piantadosi CA. 2015. Redox regulation of mitophagy in the lung during murine Staphylococcus aureus sepsis. Free Radic. Biol. Med. 78:179-89
70. Suliman HB, Piantadosi CA. 2016. Mitochondrial quality control as a therapeutic target. Pharmacol. Rev. 68(1):20-48
71. Hotchkiss RS, Karl IE. 2003. The pathophysiology and treatment of sepsis. N. Engl. J.Med. 348(2):138-50
72. Galley HF. 2011. Oxidative stress and mitochondrial dysfunction in sepsis. Br. J. Anaesth. 107(1):57-64
73. Cash TP, Pan Y, Simon MC. 2007. Reactive oxygen species and cellular oxygen sensing. Free Radic. Biol. Med. 43(9):1219-25
74. Singer M. 2014. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence 5(1):66-72
75. Haden DW, Suliman HB, Carraway MS, Welty-Wolf KE, Ali AS, et al. 2007. Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis. Am. J. Respir. Crit. Care Med. 176(8):768-77
76. Rasbach KA, Schnellmann RG. 2007. Signaling of mitochondrial biogenesis following oxidant injury. J. Biol. Chem. 282(4):2355-62
77. Berod L, Friedrich C, Nandan A, Freitag J,Hagemann S, et al. 2014. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med. 20(11):1327-33
78. West AP, Shadel GS, Ghosh S. 2011. Mitochondria in innate immune responses. Nat. Rev. Immunol. 11(6):389-402
79. VatsD,Mukundan L,Odegaard JI, Zhang L, Smith KL, et al. 2006. Oxidativemetabolism and PGC-1β attenuate macrophage-mediated inflammation. Cell Metab. 4(1):13-24
80. Islam MN, Das SR, Emin MT, Wei M, Sun L, et al. 2012. Mitochondrial transfer from bone-marrowderived stromal cells to pulmonary alveoli protects against acute lung injury. Nat. Med. 18(5):759-65
81. Finkel T, Menazza S, Holmström KM, Parks RJ, Liu J, et al. 2015. The ins and outs of mitochondrial calcium. Circ. Res. 116(11):1810-19
82. Ichinohe T, Yamazaki T, Koshiba T, Yanagi Y. 2013. Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection. PNAS 110(44):17963-68
83. Haslip M, Dostanic I, Huang Y, Zhang Y, Russell KS, et al. 2015. Endothelial uncoupling protein 2 regulates mitophagy and pulmonary hypertension during intermittent hypoxia. Arterioscler. Thromb. Vasc. Biol. 35(5):1166-78
84. Cero FT, Hillestad V, Sjaastad I, Yndestad A, Aukrust P, et al. 2015. Absence of the inflammasome adaptor ASC reduces hypoxia-induced pulmonary hypertension in mice. Am. J. Physiol. Lung. Cell Mol. Physiol. 309(4):L378-87
85. Goritzka M, Makris S, Kausar F, Durant LR, Pereira C, et al. 2015. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. J. Exp. Med. 212(5):699-714
86. Berkelhamer SK, Kim GA, Radder JE, Wedgwood S, Czech L, et al. 2013. Developmental differences in hyperoxia-induced oxidative stress and cellular responses in the murine lung. Free Radic. Biol. Med. 61:51-60
87. Sureshbabu A, Bhandari V. 2013. Targeting mitochondrial dysfunction in lung diseases: emphasis on mitophagy. Front. Physiol. 4:384
88. Otsubo C, Bharathi S, Uppala R, Ilkayeva OR, Wang D, et al. 2015. Long-chain acylcarnitines reduce lung function by inhibiting pulmonary surfactant. J. Biol. Chem. 290(39):23897-904
89. Mannam P, Shinn AS, Srivastava A, Neamu RF, Walker WE, et al. 2014. MKK3 regulates mitochondrial biogenesis and mitophagy in sepsis-induced lung injury. Am. J. Physiol. Lung. Cell Mol. Physiol. 306(7):L604-19
90. Chen BB, Coon TA, Glasser JR, Zou C, Ellis B, et al. 2014. E3 ligase subunit Fbxo15 and PINK1 kinase regulate cardiolipin synthase 1 stability and mitochondrial function in pneumonia. Cell Rep. 7(2):476-87
91. Alsuwaidi AR, Benedict S, Kochiyil J, Mustafa F,Hartwig SM, et al. 2013. Bioenergetics of murine lungs infected with respiratory syncytial virus. Virol. J. 10:22
92. Hood DA. 2001. Invited review: contractile activity-induced mitochondrial biogenesis in skeletal muscle. J. Appl. Physiol. 90(3):1137-57
93. Kirkham PA, Barnes PJ. 2013. Oxidative stress in COPD. Chest 144(1):266-73
94. Meyer A, Zoll J, Charles AL, Charloux A, Blay F, et al. 2013. Skeletal muscle mitochondrial dysfunction during chronic obstructive pulmonary disease: central actor and therapeutic target. Exp. Physiol. 98(6):1063-78
95. Lloreta J, Orozco M, Gea J, Corominas JM, Serrano S. 1996. Selective diaphragmatic mitochondrial abnormalities in a patient with marked air flow obstruction. Ultrastruct. Pathol. 20(1):67-71
96. van der Toorn M, Slebos DJ, Bruin HG, Leuvenink HG, Bakker SJ, et al. 2007. Cigarette smokeinduced blockade of the mitochondrial respiratory chain switches lung epithelial cell apoptosis into necrosis. Am. J. Physiol. Lung. Cell Mol. Physiol. 292(5):L1211-18
97. Verhamme FM, Bracke KR, Joos GF, Brusselle GG. 2015. Transforming growth factor-βsuperfamily in obstructive lung diseases.More suspects than TGF-βalone. Am. J. Respir. CellMol. Biol. 52(6):653-62
98. Kang C, Li Ji L. 2012. Role of PGC-1αsignaling in skeletal muscle health and disease. Ann. N.Y. Acad. Sci. 1271:110-17
99. Cherry AD, Suliman HB, Bartz RR, Piantadosi CA. 2014. Peroxisome proliferator-activated receptor gamma co-activator 1-α as a critical co-activator of the murine hepatic oxidative stress response and mitochondrial biogenesis in Staphylococcus aureus sepsis. J. Biol. Chem. 289(1):41-52
100. Bocci V, Valacchi G. 2015. Nrf2 activation as target to implement therapeutic treatments. Front. Chem. 3:4
101. Soulitzis N, Neofytou E, PsarrouM, Anagnostis A, TavernarakisN, et al. 2012. Downregulation of lung mitochondrial prohibitin in COPD. Respir. Med. 106(7):954-61
102. Mizumura K, Cloonan SM, Nakahira K, Bhashyam AR, Cervo M, et al. 2014. Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD. J. Clin. Investig. 124(9):3987-4003
103. Ito S, Araya J, Kurita Y, Kobayashi K, Takasaka N, et al. 2015. PARK2-mediated mitophagy is involved in regulation of HBEC senescence in COPD pathogenesis. Autophagy 11(3):547-59
104. Ahmad T, Sundar IK, Lerner CA, Gerloff J, Tormos AM, et al. 2015. Impaired mitophagy leads to cigarette smoke stress-induced cellular senescence: implications for chronic obstructive pulmonary disease. FASEB J. 29(7):2912-29
105. Patel AS, Song JW, Chu SG,Mizumura K, Osorio JC, et al. 2015. Epithelial cell mitochondrial dysfunction and PINK1 are induced by transforming growth factor-beta1 in pulmonary fibrosis. PLOS ONE 10(3):e0121246
106. Liu SF, Kuo HC, Tseng CW, Huang HT, Chen YC, et al. 2015. Leukocyte mitochondrial DNA copy number is associated with chronic obstructive pulmonary disease. PLOS ONE 10(9):e0138716
107. Postma DS, Rabe KF. 2015. The asthma-COPD overlap syndrome. N. Engl. J. Med. 373(13):1241-49
108. Zifa E, Daniil Z, Skoumi E, Stavrou M, Papadimitriou K, et al. 2012. Mitochondrial genetic background plays a role in increasing risk to asthma. Mol. Biol. Rep. 39(4):4697-708
109. Aguilera-Aguirre L, Bacsi A, Saavedra-Molina A, Kurosky A, Sur S, Boldogh I. 2009. Mitochondrial dysfunction increases allergic airway inflammation. J. Immunol. 183(8):5379-87
110. Mabalirajan U, Dinda AK, Kumar S, Roshan R, Gupta P, et al. 2008. Mitochondrial structural changes and dysfunction are associated with experimental allergic asthma. J. Immunol. 181(5):3540-48
111. Aravamudan B, Kiel A, Freeman M, Delmotte P, Thompson M, et al. 2014. Cigarette smoke-induced mitochondrial fragmentation and dysfunction in human airway smoothmuscle. Am. J. Physiol. Lung. Cell Mol. Physiol. 306(9):L840-54
112. Aravamudan B, ThompsonMA, Pabelick CM, Prakash YS. 2013. Mitochondria in lung diseases. Expert. Rev. Respir. Med. 7(6):631-46
113. Ahmad T, Mukherjee S, Pattnaik B, Kumar M, Singh S, et al. 2014. Miro1 regulates intercellular mitochondrial transport &enhances mesenchymal stem cell rescue efficacy. EMBO J. 33(9):994-1010
114. Murthy S, Adamcakova-Dodd A, Perry SS, Tephly LA, Keller RM, et al. 2009. Modulation of reactive oxygen species by Rac1 or catalase prevents asbestos-induced pulmonary fibrosis. Am. J. Physiol. Lung. Cell Mol. Physiol. 297(5):L846-55
115. Osborn-Heaford HL, Ryan AJ, Murthy S, Racila AM, He C, et al. 2012. Mitochondrial Rac1 GTPase import and electron transfer from cytochrome c are required for pulmonary fibrosis. J. Biol. Chem. 287(5):3301-12
116. Shukla A, Lounsbury KM, Barrett TF, Gell J, Rincon M, et al. 2007. Asbestos-induced peribronchiolar cell proliferation and cytokine production are attenuated in lungs of protein kinase C-knockout mice. Am. J. Pathol. 170(1):140-51
117. Panduri V, Surapureddi S, Soberanes S, Weitzman SA, Chandel N, Kamp DW. 2006. P53 mediates amosite asbestos-induced alveolar epithelial cell mitochondria-regulated apoptosis. Am. J. Respir. Cell Mol. Biol. 34(4):443-52
118. Eberle J, Hossini AM. 2008. Expression and function of Bcl-2 proteins in melanoma. Curr. Genom. 9(6):409-19
119. Antigny F, GirardinN, Raveau D, Frieden M, Becq F, Vandebrouck C. 2009. Dysfunction ofmitochondria Ca2+ uptake in cystic fibrosis airway epithelial cells. Mitochondrion 9(4):232-41
120. Evans AM, Hardie DG, Peers C,Mahmoud A. 2011. Hypoxic pulmonary vasoconstriction: mechanisms of oxygen-sensing. Curr. Opin. Anaesthesiol. 24(1):13-20
121. Kamdar O, Le W, Zhang J, Ghio AJ, Rosen GD, Upadhyay D. 2008. Air pollution induces enhanced mitochondrial oxidative stress in cystic fibrosis airway epithelium. FEBS Lett. 582(25-26):3601-6
122. Shapiro BL. 1988. Mitochondrial dysfunction, energy expenditure, and cystic fibrosis. Lancet 2(8605):289
123. Chomyn A. 2001. Mitochondrial genetic control of assembly and function of complex I in mammalian cells. J. Bioenerg. Biomembr. 33(3):251-57
124. Chatterjee A, Mambo E, Sidransky D. 2006. Mitochondrial DNA mutations in human cancer. Oncogene 25(34):4663-74
125. Yang Ai SS, Hsu K, Herbert C, Cheng Z, Hunt J, et al. 2013. Mitochondrial DNA mutations in exhaled breath condensate of patients with lung cancer. Respir. Med. 107(6):911-18
126. Kamp DW, Shacter E, Weitzman SA. 2011. Chronic inflammation and cancer: the role of the mitochondria. Oncology 25(5):400-10, 13
127. AichlerM,ElsnerM,Ludyga N, FeuchtingerA,ZangenV, et al. 2013. Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria. J. Pathol. 230(4):410-19
128. Kongara S, Karantza V. 2012. The interplay between autophagy and ROS in tumorigenesis. Front. Oncol. 2:171
129. Dasgupta S, Soudry E, Mukhopadhyay N, Shao C, Yee J, et al. 2012. Mitochondrial DNA mutations in respiratory complex-I in never-smoker lung cancer patients contribute to lung cancer progression and associated with EGFR gene mutation. J. Cell Physiol. 227(6):2451-60
130. vanWaveren C, Sun Y, Cheung HS, Moraes CT. 2006. Oxidative phosphorylation dysfunction modulates expression of extracellular matrix-remodeling genes and invasion. Carcinogenesis 27(3):409-18
131. Murphy MP, Smith RA. 2000. Drug delivery to mitochondria: the key to mitochondrial medicine. Adv. Drug Deliv. Rev. 41(2):235-50
132. Garber K. 2012. Biochemistry: a radical treatment. Nature 489:S4-6
133. Harvey CJ,Thimmulappa RK, Sethi S, Kong X, Yarmus L, et al. 2011. Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci. Transl. Med. 3(78):78ra32
134. Zhu H, Jia Z, Strobl JS, Ehrich M, Misra HP, Li Y. 2008. Potent induction of total cellular and mitochondrial antioxidants and phase 2 enzymes by cruciferous sulforaphane in rat aortic smooth muscle cells: cytoprotection against oxidative and electrophilic stress. Cardiovasc. Toxicol. 8(3):115-25
135. Geismann C, Arlt A, Sebens S, Schäfer H. 2014. Cytoprotection "gone astray": Nrf2 and its role in cancer. Onco. Targets Ther. 7:1497-518
136. Suliman HB,Welty-Wolf KE, CarrawayM, Tatro L, Piantadosi CA. 2004. Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. Cardiovasc. Res. 64(2):279-88
137. Piantadosi CA, Withers CM, Bartz RR, MacGarvey NC, Fu P, et al. 2011. Heme oxygenase-1 couples activation of mitochondrial biogenesis to anti-inflammatory cytokine expression. J. Biol. Chem. 286(18):16374-85
138. Nisoli E, ClementiE, Paolucci C, Cozzi V, Tonello C, et al. 2003. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299:896-99
139. Wang K, Klionsky DJ. 2011. Mitochondria removal by autophagy. Autophagy 7(3):297-300
140. Zhang J, Ney PA. 2009. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 16(7):939-46
141. Aich J, Mabalirajan U, Ahmad T, Khanna K, Rehman R, et al. 2012. Resveratrol attenuates experimental allergic asthma in mice by restoring inositol polyphosphate 4 phosphatase (INPP4A). Int. Immunopharmacol. 14(4):438-43
142. Mabalirajan U, AhmadT, Leishangthem GD, Dinda AK, Agrawal A, Ghosh B. 2010. L-arginine reduces mitochondrial dysfunction and airway injury in murine allergic airway inflammation. Int. Immunopharmacol. 10(12):1514-19
143. Calixto MC, Lintomen L, André DM, Leiria LO, Ferreira D, et al. 2013. Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice. PLOS ONE 8(10):e76786
144. Agrawal A, Prakash YS. 2014. Obesity, metabolic syndrome, and airway disease: a bioenergetic problem? Immunol. Allergy Clin. North Am. 34(4):785-96
145. Sexton P, Metcalf P, Kolbe J. 2014. Respiratory effects of insulin sensitisation withmetformin: a prospective observational study. COPD 11(2):133-42
146. Barbi J, Pardoll D, Pan F. 2013. Metabolic control of the Treg/Th17 axis. Immunol. Rev. 252(1):52-77
147. Lam HC, Cloonan SM, Bhashyam AR, Haspel JA, Singh A, et al. 2013. Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction. J. Clin. Investig. 123(12):5212-30
148. Gibson GJ, Loddenkemper R, Lundbäck B, Sibille Y. 2013. Respiratory health and disease in Europe: the new European Lung White Book. Eur. Respir. J. 42(3):559-63